M&A Deal Summary |
|
|---|---|
| Date | 2020-09-01 |
| Target | GNC |
| Sector | Retail |
| Buyer(s) | Harbin Pharmaceutical Group |
| Deal Type | Special Situations/Distressed |
| Deal Value | 770M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 10,180 |
| Revenue | 16.2B CNY (2024) |
Harbin Pharmaceutical Group is a domestic pharmaceutical company. The Company is a large-scale and efficient manufacturer and distributor of generic antibiotics drugs. Harbin Pharmaceutical Group was founded in 1991 and is based in Harbin, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Retail M&A | 2 of 2 |
| Type: Special Situations/Distressed M&A Deals | 1 of 1 |
| State: Pennsylvania M&A | 2 of 2 |
| Country: United States M&A | 2 of 2 |
| Year: 2020 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-01 |
GNC
Pittsburgh, Pennsylvania, United States GNC is the largest global specialty retailer of health and wellness products, with 4,200 retail locations in the United States and franchise operations in 48 international markets. GNC products include vitamins, minerals, and other wellness products. GNC was established in 1935 and is based in Pittsburgh, Pennsylvania. |
Sell | - |
